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1. Introduction 
The glycogen stored in the liver is used as a reserve 
of glucose for the blood at the benefit of other 
tissues, mostly brain, erythrocytes and muscle; the he- 
patocyte itself uses only a small part of its carbohy- 
drate for its own metabolic needs. It is therefore not 
surprising that, in the liver, the metabolism of glyco- 
gen is tightly regulated by the level of glycemia nd by 
several hormones according to the general demand. In 
muscle, on the contrary, glycogen is a glycolytic fuel 
for the supply of ATP in anaerobic onditions and its 
metabolism is much more under the control of local 
factors. 
In this review we shall discuss the enzymic mecha- 
nisms by which the metabolism of glycogen in the liver 
is controlled by glucose, glucocorticoids, glucagon and 
by glycogen itself. Insulin seems also to play a role, but 
its mode of action so far remains mysterious. A brief 
comparison between the regulation of glycogen metab- 
olism in liver and muscle will be drawn. 
* "Bevoegdverklaard Navorser" of N.F.W.O. 
** "Aangesteld Navorser" of N.F.W.O. 
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Fig. 1. Interactions of the enzymes controlling lycogen metabolism in the liver. 
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2. The rate limiting enzymes; their phosphorylation 
and dephosphorylation 
As wiU be shown in section 3, the rate of glycogen 
synthesis in the liver is parallel to the activity of gly- 
cogen synthetase. There is also good evidence that gly- 
cogen degradation is entirely controlled by the activ- 
ity of phosphorylase. This review will therefore be re- 
stricted to the control of these two rate limiting en- 
zymes. Each of them exists in two forms, that are inter- 
convertible by phosphorylation a d dephosphorylation 
as schematically represented in fig. 1. The liver contains 
a phosphorylase phosphatase [ 1] and a phosphorylase 
kinase [2] ; the latter enzyme is more active in the pres- 
ence of cydic AMP (see section 6). The liver phospho- 
phosphorylase (phosphorylase a) is the active form of 
the enzyme; its activity is increased by 15 to 40% upon 
the addition of 10 -3 M AMP [3,4]. The dephosphoen- 
zyme (phosphorylase b) is completely inactive in the 
absence of AMP; its activity in the presence of the nu- 
cleotide is nearly zero in pig or rabbit liver [5], but 
reaches 15% of phosphorylase a in dog liver [3] and 25% 
in mouse liver [6]. 
The inactivation of glycogen synthetase in the pres- 
ence of ATP in a muscle extract and the stimulation of 
this reaction by cyclic AMP was described in 1961 by 
Belocopitow [7]. The conclusive vidence that the 
muscle enzyme xists in two forms interconvertible by
phosphorylation a d dephosphorylation was later ob- 
tained by Friedman and Larner [8]. It is highly prob- 
able, although not definitively proven, that the same 
system occurs in the liver [9-11 ]. The main difference 
between phosphorylase and synthetase is that the active 
forms are the phosphophosphorylase and the dephos- 
phosynthetase. 
Liver phosphosynthetase requires glucose-6-phos- 
phate for its activity; it is completely inactive in the 
presence of a physiological concentration of inorganic 
phosphate [ 12] whereas the dephosphoenzyme is nearly 
fully active in the same conditions [13]. One form is 
therefore inactive and the other active in vivo, what- 
ever the concentration ofglucose-6-phosphate. Other 
properties of the two forms have been described 
[ 12-16]. The phospho- and the dephosphosynthetase 
have been called respectively D (glucose-6-phosphate 
dependent) and I (glucose-6-phosphate independent) 
by Hizukuri and Lamer [14], b (inactive) and a (ac- 
tive) by Mersmann and Segal [13]. The D and I desig- 
nation is misleading because it gives the false impres- 
sion that glucose-6-phosphate might be of importance 
in the in vivo activity of glycogen synthetase. We shall 
use only the a and b nomenclature, which conforms to 
that initially introduced by Cori and Green [17] for 
the 2 forms of muscle phosphorylase. 
3. The conversion of the rate limiting enzymes 
in vivo 
3.1. The effect of  glucose and glycogen 
There is ample experimental evidence that glycogen 
synthesis and degradation are controlled by the con- 
centration of glucose in the blood. A deposition of 
• 10 mg polysaccharide/hr/g liver has been observed 
after fasting and refeeding in adrenalectomized [ 18, 
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Fig. 2, Correlation between the activity of liver glycogen 
synthetase a measured at 0 ° and the rate of the in vivo con- 
version of glucose to liver glycogen in the same animal. The 
in vivo conversion was measured by the incorporation of 6- 
3H-glucose in 1 min; (o) control mice; (e) mice injected with 
glucose (1 mg]g, i.v. 5 min before the experiment); (u) pred- 
nisolone treated mice (1 mg/20 g, s.c. 3 hr before); (m) pred- 
nisolone treated mice injected with glucose. Correlation coef- 
ficient 0.94 (p (0 .001) .  From De Wulf and Hers [28]. 
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Fig. 3. Change in the rate of glycogen synthesis after a single 
glucose load. Glucose was injected intravenously into mice 
fasted for 24 hr in a single dose of 1 mg/g body weight. At 
various intervals afterwards, a trace amount of U-14C-glucose 
was administered intravenously and the animals were killed 1 
rain later. (o) glucose concentration in the liver at the end of 
the experiment; (o) amount of glucose converted into glyco- 
gen in 1 min. Vertical bars represent + the standard error of 
the means; the number of experiments is given in parentheses. 
From De Wulf and Hers [ 22]. 
19] and in diabetic rats [20, 21 ] as well as in normal 
animals. 
It is now firmly established [22] that the increase 
in the rate of glycogen synthesis due to glucose is not 
the result of a push given along the metabolic path- 
way leading to glycogen. The glucose ffect is indeed 
much greater than the change in glycemia nd is con- 
comitant with a decrease in the intrahepatic concentra- 
tion of the intermediary metabolites: UDPG and glu- 
cose-6-phosphate. The decisive ffect of the admin- 
istration of glucose is the conversion of glycogen syn- 
thetase into its active form. The in vivo rate of glyco- 
gen synthesis i indeed highly correlated with the 
amount of synthetase a in the liver (fig. 2). 
When a glucose load is given intravenously, the rate 
of glycogen synthesis starts to increase only after a 
short latency (see fig. 3), reaches its maximum after 
5 to 6 min and then decreases progressively to come 
back to the initial value soon after the glycemia has 
been normalized [22]. The latency indicates that the 
effect of glucose on the activity of synthetase is in- 
direct. As this effect has been obtained in animals 
made acutely diabetic by the administration f anti- 
insulin serum [23], it seems not to be mediated by 
insulin. In agreement with this conclusion, the activ- 
ation of glycogen synthetase by a glucose load has 
been recently observed in perfused rat liver [24, 25]. 
An increase in the concentration f glucose in vivo 
[26-28] or in the isolated perfused liver [24, 25] 
initiates a slight decrease in the amount of active phos- 
phorylase; this effect is much!less striking than that on 
glycogen synthetase. It is a usual finding that the activ- 
ity of phosphorylase a measured in a fresh liver homo- 
genate largely exceeds what would be expected from 
the actual rate of glycogenolysis. This maybe due to a 
very rapid activation of the enzyme in the process of 
homogenization r to some other reasons. In the dog 
only, very low values of liver phosphorylase have been 
observed after the administration ofglucose and insulin 
[29]. 
The effect of glycogen concentration  the rate 
of glycogen synthesis has, to our knowledge, not been 
systematically investigated. In the muscle, there is an 
inverse relationship between the glycogen content 
of the tissue and the percentage of synthetase in the 
active form [30] and this has been explained by an 
inhibition of glycogen synthetase phosphatase by 
glycogen [31 ]. Although the liver can accumulate 
glycogen to a much higher concentration than the 
muscle, it appears probable that there exists in this 
tissue also a feedback mechanism that prevents the 
excessive deposition of the polysaccharide. 
3.2. The effect of  insulin 
It has been observed repeatedly that insulin, when 
given together with glucose, causes aglycogen depo- 
sition in the liver [32, 33] and, more recently, this 
effect has been attributed to an activation of glycogen 
synthetase [29]. As glucose given alone is also very 
efficient, it is not easy to dissociate what part of the 
effect is due to insulin itself. It seems, hOwever, that, 
with insulin, the effect of a glucose load is obtained 
at a lower level of glycemia [22]. 
Insulin alone does not induce an activation of 
glycogen synthetase in the liver of normal animals, 
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at least within a few minutes [6]. It does, however, 
activate the enzyme within 5 to 15 min in diabetic 
rats, if administered only two days after the alloxan 
treatment [34, 35], and this effect is not related to 
a drop in the concentration of cyclic AMP in the liver 
[34]. An activation can also be obtained in rats that 
have been diabetic for a longer time, but then it re- 
quires about one hour [36]. 
3.3. The effect of glucocorticoids 
The stimulation of liver glycogen synthesis by glu- 
cocorticoids was described in 1940 by Long et al. [37] ; 
it was observed both in normally fed and in fasted 
animals and is therefore not secondary to the stimul- 
ation of gluconeogenesis. Accordingly, glucocorticoids 
increase the rate of conversion of blood glucose into 
liver glycogen [38, 39]. The effect has also been ob- 
tained in diabetic animals [40, 41] and is therefore 
not insulin-dependent; contradictory results [34, 42] 
have been obtained only in experiments which were 
of too short duration (2 hr). 
The glucocorticoids require approximately 3 hr to 
stimulate glycogen synthesis. At that time, the con- 
centration of glucose-6-phosphate nd UDPG are mar- 
kedly reduced in the cell and the synthetase is converted 
into its active form [43, 44]. Here also, there is a strik- 
ing parallelism between the activity of glycogen syn- 
thetase and the actual rate of glycogen synthesis (see 
fig. 2). It is also shown in the same figure that the admin- 
istration of glucose to mice treated with prednisolone 
35 hr previously, further increases the activity of glycogen 
synthetase and the rate of glycogen synthesis. 
After the administration of corticoids, there is a de- 
crease in the activity of glycogen phosphorylase [28].. 
This decrease is however much less important than the 
activation of glycogen synthetase 
I 
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3.4. The effect of glucagon 
Sutherland and Cori [45] were the first to observe 
that epinephrine and glucagon cause the activation of 
phosphorylase in liver slices. Due to the high basal ac- 
tivity of phosphorylase a (see section 3.1 .) the changes in 
phosphorylase activity induced by the hormone in vivo 
or in a perfused liver, are proportionally much smaller 
than the changes in glucose production. In the experi- 
ment taken from Weintraub et al. [46] and reported 
in fig. 4, there is a two fold increase in enzymic activ- 
ity but a 10 to 20 fold increase in glucose production. 
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Fig. 4. Correlation between the changes inthe activity of liver 
glycogen phosphorylase and in glucose output in perfused rat 
liver. For each liver, the mean change in glucose output is plot- 
ted as a function of the mean change in phosphorylase activity. 
For the control ivers, base line phosphorylase activity averaged 
11 U/g and glucose output 0.025 mg/min/g liver. (o) control 
livers; (*) livers perfused with glucagon (from 0.01 to 5 ~g). Cor- 
relation coefficient: 0.84 (p <0.001). This figure was drawn 
with the data in tables 1 and 2 in Weintraub et al. [46]. 
One observes, however, agood correlation between the 
two effects. In vivo, the increase in the activity of 
phosphorylase is also about 2 fold [47] or much less 
[27, 28]. The effect of glucagon on glycogen syn- 
thetase is more apparent as a nearly complete inactiv- 
action of the enzyme can be obtained [28,29]. The 
hormone cancels the activation of glycogen synthetase 
by glucose and also reduces considerably the activity 
of the enzyme that has been activated by glucocorti- 
coids. Cyclic AMP or epinephrine have a similar effect 
when given intravenously. This inactivation is obtained 
in 1 to 3 min [28]. At physiological concentration, 
glucagon is much more glycogenolytic than is epine- 
phrine [48]. 
The increase in the concentration of cyclic AMP 
in the liver after the administration of a small dose 
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(0.5 ng/g) of glucagon to mice precedes the inactiva- 
tion of glycogen synthetase by 1-2 rain [49]. This 
sequence of events is in agreement with the role of 
the nucleotide as second messenger in the hormonal 
action. 
4. The control of phosphorylase phosphatase by 
glucose, glycogen or glucocorticoids 
The regulation of phosphorylase phosphatase is 
most conveniently studied in a liver extract hat has 
been fdtered through acolumn of Sephadex G-25 [50]. 
In this preparation, obtained from fed mice, the con- 
version of phosphorylase a into b at 20 ° is complete 
in approximately 20 min. This is schematically repre- 
sented by the descending full line in fig. 5. The con- 
version is accelerated ( otted line a, in fig. 5) by glu- 
cose, caffeine or nicotinamide added to the prepara- 
tion, and retarded (dotted line r) by glycogen. The 
stimulation of liver phosphorylase phosphatase by glu- 
cose is apparently specific for this hexose as it was not 
obtained with any other sugar or sugar derivative that 
was asayed. It is concentration dependent with an ap- 
parent K m equal to 0.13 g/100 ml (7 mM) glucose 
and is additive to the effect of caffeine. 
When the liver is obtained from mice that have been 
treated with prednisolone a few hours previously, the 
activity of phosphorylase phosphatase is 3 to 10 times 
higher than normal (dotted line a) and can be further 
stimulated by glucose or caffeine (dotted line a'). As 
the action of glucocorticoids on glycogen synthesis 
requires everal hours to be complete and as the pro- 
perties of phosphorylase phosphatase appear not to be 
modified by the treatment, it is very probable that the 
steroids initiate a more rapid synthesis of the enzyme. 
The observations reported in this paragraph give an 
appropriate explanation for the lower activity of phos- 
phorylase in the liver in vivo after a treatment of the 
animals with glucose [26-28] or with glucocorticoids 
[281. 
5. The control of synthetase phosphatase by 
phosphorylase 
In a fresh liver extract, glycogen synthetase is mostly 
in the b form and can be converted into a by incubation 
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Fig. 5. Schematic representation f the inactivation O f phos- 
phorylase (descending lines) and of the activation of glycogen 
synthetase (ascending lines) as observed in a liver Sephadex 
filtrate incubated at 20 °. c) control filtrate; a) control filtrate 
incubated in the presence of 0.5% glucose or filtrate from mice 
treated with prednisolone; a') filtrate from mice treated with 
prednisolone incubated in the presence of 0.5% glucose; r) con- 
trol filtrate incubated in the presence of 6% glycogen. The 
original data from which the scheme is constructed can be 
found in [50, 52, 53]. 
at 20°; this conversion is, however, preceded by a la- 
tency period of approximately 20 min [51 ]. The activa- 
tion pattern is best evidenced when all the synthetase has 
been first converted into the b form by an injection 
of glucagon shortly before sacrifice and when the' liver 
extract has been filtered through SephadexG-25 [ 2]. 
The activation then occurs as schematically shown in 
fig. 5 by the ascending curve c (full line). With this 
preparation, it has been observed that all effectors 
(glucose, caffeine, nicotinamide and glucocorticoids) 
that increase the activity of phosphorylase phosphat- 
ase, also shorten the latency period in the activation 
of glycogen synthetase (ascending lines a and a'); gly- 
cogen has the reverse ffect (ascending line r). In all 
conditions the latency period corresponds to the time 
required to inactivate phosphorylase. The activity of 
synthetase phosphatase itself (slope of the ascending 
curve) is not modified by the effeetors, except by 
glycogen which causesa slight inhibition: 
These facts were explained when it was shown [53] 
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that ph. osphorylase a is-a strong inhibitor of liver syn- 
thetase phosphatase: when added before the end of the 
latency, it delays the activation of glycogen synthetase; 
when added later, it stops the reaction, causing the ap- 
pearance of a new latency. Phosphorylase b is much 
less inhibitory. The inhibition of synthetase phospha- 
tase by phosphorylase a is cancelled by AMP; the acti- 
vation of glycogen synthetase proceeds then without 
latency and at a rapid rate. The latency is also suppres- 
sed when phosphorylase is combined with specific anti- 
bodies. It is clear therefore that the latency is entirely 
explained by the inhibitory action of phosphorylase a.
The previous uggestion [52, 54] that synthetase phos- 
phatase might exist in two interconvertible forms has 
thus been disproved. 
The activation in vivo of glycogen synthetase by glu- 
cose or glucocorticoids i therefore also explained by 
the increased activity of phosphorylase phosphatase; 
once phosphorylase is inactivated, synthetase phosphat- 
ase, now released from inhibition, can activate glycogen 
synthetase. 
Synthetase phosphatase r quires the presence of a 
small amount of glycogen to be active in vitro. It is 
poorly active in preparations obtained from fasted ani- 
mals, but recovers its full activity if 0.5% glycogen is: 
added [6, 55]. The enzyme is also inactive in liver ex- 
tracts [56] and in perfused livers [25] obtained from 
fasted adrenalectomized rats, despite the fact that gly- 
cogen synthesis rapidly occurs in vivo upon refeeding 
of these animals [18, 19]. 
The activation of glycogen synthetase proceeds at a 
normal rate in a liver filtrate obtained from alloxan 
diabetic mice [6]. Synthetase phosphatase has however 
been reported to have lost a part of its activity in the 
liver of diabetic animals [35, 54]. It is not clear if the 
latter effect can be explained by a lack of glycogen or by 
an excess of phosphorylase a in the preparation. In vivo, 
fasted diabetic rats synthetize glycogen upon refeeding 
at an essentially normal rate [20, 21 ]. 
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Fig. 6. The influence of ATP and cyclic AMP on the inactiva- 
tion of glycogen synthet~se, A liver extract was obtained from 
mice injected with glucose (2 mg/g) 6 min before death. This 
extract, at a final concentration f 12.5%, was incubated at 
20 ° in 100 mM NaF, 5 mM caffeine and 5% glycogen either 
without further addition (.) or in the presence of 2.5 mM 
ATP and 2.5 ml~.~ Mg acetate (o)or 2.5 mM ATP, 2.5 mM Mg 
acetate and 10 jaM cyclic AMP (z~). From De Wulf and Hers [9]. 
tivated and non-activated form [58] ; the activation oc- 
curs by phosphorylation through a phosphorylase ki- 
nase kinase that is cyclic AMP dependent [59]. This 
kinase kinase acts also on other proteins [60], including 
the dephosphosynthetase [61,62] and has been cal- 
led a "protein kinase" [60]. It is probable, although 
not demonstrated, that the same cascade of reactions 
occurs in the liver [63]. 
In a liver extract, glycogen synthetase kinase is 
stimulated by cyclic AMP (see fig. 6) and has a K m 
that is also close to 2 X 10 -7 M [9, 64]. A partially 
purified kinase displays, however, a slightly higher 
affinity [ 10]. The muscle protein kinase inactivates 
liver synthetase a [11 ]. 
6. The control of the kinases by cyclic AMP 
In a liver extract, phosphorylase kinase is stimulated 
by cyclic AMP; a half maximal effect is obtained with 
2 × 10 -7 M nucleotide [57]. The muscle enzyme has 
been extensively purified, and, in that case, it has been 
shown that phosphorylase kinase itself exists as an ac- 
78 
7. A comparison between liver and muscle 
A detailed account of the regulation of glycogen 
metabolism in the muscle exceeds the scope of this 
review. It is however of interest o underline the dif- 
ferences that exist between the liver and muscle sys- 
tems. 
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Muscle glycogen synthetase D (b) is less inhibited 
by inorganic phosphate than the liver b enzyme [65, 
66]. The concentration f glucose-6-phosphate in- 
creases markedly in muscle during tetanic ontrac- 
tion and may be sufficient to allow the D form to be 
active [67]. The regulation of glycogen synthesis in 
the muscle operates therefore not only by intercon- 
version of the active and inactive forms of the synthe- 
tase but also by a change in the concentration f glu- 
cose-6-phosphate [67]. 
As there is no free glucose in muscle [68], a control 
of glycogen metabolism by the level of glycemia is not 
possible. Phosphorylase phosphatase is,however, slight- 
ly stimulated by glucose [69] and this effect has recently 
been shown to be dependent upon the presence of 
AMP [70]. Another important difference between the 
two tissues is that muscle synthetase phosphatase is not 
inhibited by phosphorylase [71 ]. Finally, it seems that 
in muscle the main stimulator of phosphorylase kinase 
is Ca 2 + [72], which is released at the onset of muscular 
contraction. 
8. Conclusion 
8.1. The overall mechanism 
We summarize in fig. 7 the biochemical mechanisms 
that regulate glycogen metabolism in the liver. The 
level of active phosphorylase and of active synthetase • 
is controlled by the antagonistic effects of the kinases 
and phosphatases. It has been shown that, at least in 
the muscle, the same protein kinase acts as a phosphor- 
ylase kinase kinase and as a synthetase kinase. This en- 
zyme is cyclic AMP-dependent and its action causes the 
arrest of glycogen synthesis together with the onset of gly- 
cogenolysis. Phosphorylase phosphatase is stimulated 
by glucose, inhibited by glycogen, and its total amount 
is augmented by glucocorticoids. Being controlled both 
on the side of its kinase and of its iphosphatase, phos- 
phorylase is the most highly regulated enzyme in the 
system. By its action on synthetase phosphatase, phos- 
phorylase acts as a second messenger in the control of 
glycogen synthesis by glucose and by glucocorticoids. 
These latter agents are antagonistic to cyclic AMP: they 
cause the arrest of glycogenolysis, followed by the 
onset of glycogen synthesis. 
When protein kinase is stimulated by cyclic AMP, 
synthetase phosphatase is inactive, due to the inhibi- 
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Fig. 7. The regulation of glycogen metabolism in the liver [53]. 
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tion by phosphorylase a; there is therefore no futile 
recycling of the two forms of glycogen synthetase 
when the level of cyclic AMPis elevated. It appears 
very probable however that, in other circumstances, 
the kinases and the phosphatases operate simulta- 
neously, and that the actual evel of active phosphor- 
ylase or of active synthetase is the result of a balance 
between phosphorylation a d dephosphorylation. If 
this was not the case, phosphorylase and synthetase 
would always be 100% active or 100% inactive. Yet, 
we know that phosphorylase is not necessarily com- 
pletely in the a form when the level of cyclic AMP 
is elevated: this indicates that the stimulated kinase 
is kept in check by the phosphatase, stimulated itself 
by a higher glucose level. 
At normal evels of glycemia, the synthetase is al- 
most entirely in the inactive form and can be activ- 
ated by glucose within a few minutes or by glucocorti- 
coids within a few hours. This implies that some of 
the phosphorylase was in the active form. Under the ac- 
tion of glucose or of glucocorticoids, the inactivation 
of phosphorylase is presumably almost complete, other- 
wise synthetase phosphatase would not operate. As 
the two treatments have additive ffects, it appears 
that each of them separately is unable to increase 
phosphatase activity up to the point where it com- 
pletely overcomes the kinase. Under the same condi- 
tions, the activation of synthetase is also incomplete 
(see fig. 2), indicating that synthetase phosphatase has 
to compete with synthetase kinase. 
8.2. Regulation by glucose 
The abundance of glucose in the body governs 
the flow of many metabolites and more particularly 
controls the carbohydrate store in the liver. This has 
now been explained by an apparently direct control 
of phosphorylase phosphatase by glucose. This effect 
is shared by no other sugar and explains that glycogen 
degradation is stopped when the concentration f
glucose is elevated and vice versa. By accelerating the 
conversion of phosphorylase a into b, a high glucose 
level allows the activation of glycogen synthetase. This 
indirect effect explains the latency that precedes the 
activation of glycogen synthetase in vivo as well as in 
vitro. 
The apparent K m of phosphorylase phosphatase for 
glucose in a liver Sephadex filtrate is of the order of 
0.13 g/100 ml. If the same value applies in vivo, the 
enzyme would be about 50% active at normal 
glucose concentration (0.15 g/100 ml in fed mice). 
Under this condition, however, synthetase is still 
mostly in the inactive form, indicating that phospho- 
rylase a is present. This situation can be understood 
if the activity of phosphorylase phosphatase atnor- 
mal level of glycemia is balanced by the basal activity~ 
of phosphorylase kinase; only an excess of glucose will 
allow the phosphatase to overcome the kinase. 
8.3. Regulation by insulin 
We do not know, at the present time, how insulin 
might interfere with one of the regulatory mechanisms 
shown in fig. 7. 
8.4. Regulation by glucocorticoids 
Glucocorticoids allow the synthesis of glycogen 
to proceed in the fasting state, i.e. at a low glucose 
level, and they bring the concentration f polysac° 
charide up to very high values. These effects are easily 
explained by the large increase in phosphorylase phos- 
phatase caused by treatment with these hormones. As 
shown by the dotted line a in fig. 5, this activity in 
the absence of glucose is now equal to that obtained 
normally under full stimulation by the hexose. Corti- 
coid treatment has thus the same effect as protracted 
hyperglycemia. Furthermore, a higher concentration 
of glycogen will be required in order to reduce the ac- 
tivity of the excess of phosphorylase phosphatase to
the critical point where eventually no more glycogen 
synthesis occurs. 
8.5. Regulation by glucagon 
Great emphasis has been put on the regulation 
of glycogen breakdown by glucagon, presumably be- 
cause its mechanism has been clear for many years. 
It now appears that glucagon ot only activates gly- 
cogen phosphorylase but also prevents glycogen syn- 
thesis by the double lock of a stimulation of synthe- 
tase kinase and of an inhibition of synthetase phos- 
phatase by phosphorylase a. It appears too that this 
is only one part of the regulatory mechanism and 
that glucose concentration is also of great importance. 
It is not clear, at the present time, whether the glyco- 
genolysis in the fasting state is initiated by the hypo- 
glycemia itself or by a secondary secretion of glucagon. 
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